Trumps AntiWeaponization Fund Faces Opposition from Nearly Half of MAGA Supporters Poll Shows
Snowflake Shares Surge 36 After Earnings Beat and 6 Billion Amazon Cloud Commitment
Agnico Eagle Mines Announces 24 Billion Hope Bay Mine Redevelopment Amid Strong Earnings Momentum
EU Imposes 230 Million Fine on Temu for Illegal Product Sales
Southern Copper Corporation SCCO Draws Mixed Analyst Views Amid Commodity Supercycle Speculation
China Urges APEC Cooperation as Commerce Minister Skips Meeting Over Urgent Official Business
AIFF Q3 1998 Earnings EPS Plunges to 1290 Missing Estimates by 483
PRF Technologies PRFX Q2 2024 Earnings Deep EPS Miss as Operating Losses Widen
CUZ Q1 2026 Earnings EPS Beat Highlights Operational Resilience
WGRX Q1 2026 Earnings Negative EPS and No Revenue Reported Stock Plunges 22
ATOS Q1 2026 Earnings Loss Narrows Significantly Beating Estimates by 82
ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Amid Mixed Consumer Demand
NewHold Investment Corp III NHIC Holds Steady Near Resistance SPAC Trading in Tight Range
Crane Company CR Gains 15 as Shares Approach Key Resistance Levels
Carlisle Companies CSL Edges Higher Holding Near Key Support
A SPAC III Acquisition Corp Unit ASPCU Rises 378 as Momentum Builds Toward Key Resistance
ADAMH Steady Near Par Adamas Senior Notes Hold Ground Amid Low Volatility
Piper Sandler Warns Strait of Hormuz Closure Could Drive Oil to New Highs This Summer
QuidelOrtho Q1 2026 Earnings EPS Misses Estimates Sharply Stock Declines 428
Biofrontera Inc BFRI Edges Higher A SmallCap Biotech Finds Temporary Footing
XMAX Inc XWIN Holds Steady at 824 as Traders Eye Key Levels
ADAMH Senior Notes Edge Lower Income Focus Amid Narrow Trading Range
Reservoir Media Inc RSVR Holds Steady at 1020 as Market Awaits Catalysts
Destiny Tech100 DXYZ Slides 68 as Support Level Beckons
Yorkville Acquisition Corp Warrant MCGAW Holds Steady at 036 as Investors Eye Key Support Zone
Aimei Health Technology Rights AFJKR Consolidates at 029 Amid Low Volatility
Jupiter Neurosciences Jumps 135 as Speculative Interest Builds in SmallCap Biotech